Eagle Biologics Overview

  • Founded
  • 2013

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $78.2M

Eagle Biologics General Information

Description

Operator of a biopharmaceutical agency intended to develop innovative protein formulation. The company's biopharmaceutical agency produces high-concentration drugs and related products with low viscosity, suitable for small-volume subcutaneous injection, enabling clients to avail improved access to highly viscous protein therapeutics.

Contact Information

Website
www.arsiarx.com
Formerly Known As
Arsia Therapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Delivery
Primary Office
  • Kendall Square
  • Cambridge, MA
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eagle Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 16-Nov-2016 $78.2M 000.00 Completed Generating Revenue
2. Early Stage VC Completed Startup
1. Accelerator/Incubator Completed Startup
To view Eagle Biologics’s complete valuation and funding history, request access »

Eagle Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biopharmaceutical agency intended to develop innovative protein formulation. The company's biopharmaceutic
Biotechnology
Cambridge, MA
00.00 0000-00-00
000000&0

000000

ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor i
0000000000000
Sheffield, United Kingdom
000000000000

000000

ctetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim a
0000 000000000
Little Chesterford, United Kingdom
00 As of 0000
000.00
00.00 0000-00-00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eagle Biologics Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Protein Ark Private Equity-Backed Sheffield, United Kingdom 000000000000
000000 Formerly VC-backed Little Chesterford, United Kingdom 00 000.00 00000000 000.00
000000000 00000000 Venture Capital-Backed Cambridge, United Kingdom 00 00000 0000000000 0 00000
00000 Formerly VC-backed Cambridge, United Kingdom 000 00000 000000&0 00000
00000 000000000000 Venture Capital-Backed Didcot, United Kingdom 0 00000 0000000000 0 00000
You’re viewing 5 of 13 competitors. Get the full list »

Eagle Biologics Executive Team (5)

Name Title Board Seat Contact Info
Charles Wescott Ph.D Vice President of Research & Development
Alexander Klibanov Co-Founder
Robert Langer Co-Founder
You’re viewing 3 of 5 executive team members. Get the full list »

Eagle Biologics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johnson & Johnson Innovation - JLABS Accelerator/Incubator 000 0000 000000 0
Polaris Partners Venture Capital Minority 000 0000 000000 0
To view Eagle Biologics’s complete investors history, request access »